Tag Archives: Hepatitis C

CI & Patent News: 23/11/2010a

1) Vertex Completes New Drug Application for Telaprevir for Hepatitis C (Link) 2) Gilead Sciences Submits New Drug Application to U.S. FDA for Once-Daily Single-Tablet Regimen of Truvada® (emtricitabine and tenofovir disoproxil fumarate)and TMC278 (rilpivirine hydrochloride) for HIV (Link) 3) Wockhardt Ltd. has … Continue reading

Posted in Daily interesting IP news | Tagged , , , | Leave a comment